We at Roche India, are guided by our bold vision statement: “We inspire people to transform healthcare in India and care for every patient’s life through sustainable, innovative solutions”. Our strong network of over 100 distributors, and a workforce of over 250 committed employees strive tirelessly each day to realize this vision.
For more than 60 years, Roche has been committed to making a difference to the lives of people in India. From being a key distribution market for the iconic cough syrup Sirolin, to manufacturing vitamins in the late 1950s to the recent advanced immunotherapy medicines for treating different forms of cancer, we have endeavored to bring the most innovative and path-breaking drugs to Indian patients. Today, we have a cutting-edge exclusive product portfolio of power brands across our focus therapy areas of:
Apart from our core portfolio in the above therapy areas, we also have a robust product portfolio of non exclusive brands, marketed and distributed through our partnerships with Cipla and Entero.
We are cognizant of the fact that the Indian healthscape is a varied and complex one, with several structural issues. In order to make our innovative therapies truly accessible, Roche Pharma India adopted a pioneering business operating model, the first-of-its kind to be implemented in the Indian pharma industry. Our unique decentralized cluster based operating model, allows us the agility to respond to customer needs in a faster and more efficient manner; while serving our patients seamlessly. With a strong foundation set in place, Roche Pharma India is poised to deliver greater impact in the years to come. With an impressive pipeline of 20+ new product launches and indication extensions planned in the next 3-5 years in the areas of Oncology, Hematology, Ophthalmology, Neurology and Infectious Diseases, we truly are dedicated to transforming patient lives.
Grappling with any disease can take a major toll, be it physically, emotionally or financially; not just for the patient but even for their caregivers. At Roche Pharma India, our flagship patient support program - The Blue Tree - aims to extend support and care at every step of a patient’s journey. The Blue Tree Program provides cancer, hemophilia and rare disease patients, and their families with disease awareness and testing, funding solutions, home delivery of medicines, free drug support, treatment adherence support, reimbursement support and standardized reports. The Blue Tree Program aims to truly simplify the patient’s journey.